Patent Yard Sign in
Canadian application, no grantCanada

Novel uses for gal4-receptor constructs

CA 2180271 A1 · Owner: Blumberg, Bruce · Inventors: Blumberg, Bruce; Umesono, Kazuhiko; Evans, Ronald M.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

In accordance with the present invention it has been discovered that chimeric receptors comprising at least the ligand binding domain of a member of the steroid/thyroid receptor protein superfamily having incorporated therein the DNA binding domain of the yeast GAL4 protein are capable of forming functional homodimers. Such homodimers are useful for example, in assays to determine the ligand for an orphan member of the steroid/thyroid superfamily of receptors for identifying compounds which are selective for a specific steroid/thyroid receptor protein from among a plurality of such receptors which respond to a common ligand and the like.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 29, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 29, 2014.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 29, 2016.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 29, 1994
GrantedNo grant recorded
Term endedDecember 29, 2014
Patent numberCA 2180271 A1
Classification (IPC)C12Q1/68 +2 more

Timeline

Timeline From CIPO dates

1995199719992001200320052007200920112013Application filedDec 29, 1994Term endedDec 29, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.